BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 16962775)

  • 1. Separation of anti-angiogenic and cytotoxic activities of borrelidin by modification at the C17 side chain.
    Wilkinson B; Gregory MA; Moss SJ; Carletti I; Sheridan RM; Kaja A; Ward M; Olano C; Mendez C; Salas JA; Leadlay PF; vanGinckel R; Zhang MQ
    Bioorg Med Chem Lett; 2006 Nov; 16(22):5814-7. PubMed ID: 16962775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biosynthesis of the angiogenesis inhibitor borrelidin: directed biosynthesis of novel analogues.
    Moss SJ; Carletti I; Olano C; Sheridan RM; Ward M; Math V; Nur-E-Alam M; Braña AF; Zhang MQ; Leadlay PF; Méndez C; Salas JA; Wilkinson B
    Chem Commun (Camb); 2006 Jun; (22):2341-3. PubMed ID: 16733573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological evaluation of novel curcumin analogs as anti-cancer and anti-angiogenesis agents.
    Adams BK; Ferstl EM; Davis MC; Herold M; Kurtkaya S; Camalier RF; Hollingshead MG; Kaur G; Sausville EA; Rickles FR; Snyder JP; Liotta DC; Shoji M
    Bioorg Med Chem; 2004 Jul; 12(14):3871-83. PubMed ID: 15210154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-activity relationship studies of illudins: analogues possessing a spiro-cyclobutane ring.
    McMorris TC; Cong Q; Kelner MJ
    J Org Chem; 2003 Dec; 68(25):9648-53. PubMed ID: 14656090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Total synthesis as a resource in drug discovery: the first in vivo evaluation of panaxytriol and its derivatives.
    Yun H; Chou TC; Dong H; Tian Y; Li YM; Danishefsky SJ
    J Org Chem; 2005 Dec; 70(25):10375-80. PubMed ID: 16323847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of cytotoxic novel 9,11-secosterol analogs: Structure/activity studies.
    Kongkathip B; Hasakunpaisarn A; Boonananwong S; Kongkathip N
    Steroids; 2010 Dec; 75(12):834-47. PubMed ID: 20470813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel prodrugs of tegafur that display improved anticancer activity and antiangiogenic properties.
    Engel D; Nudelman A; Tarasenko N; Levovich I; Makarovsky I; Sochotnikov S; Tarasenko I; Rephaeli A
    J Med Chem; 2008 Jan; 51(2):314-23. PubMed ID: 18163551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Encapsulation of dual cytotoxic and anti-angiogenic gold(III) complexes by gelatin-acacia microcapsules: in vitro and in vivo studies.
    Yan JJ; Sun RW; Wu P; Lin MC; Chan AS; Che CM
    Dalton Trans; 2010 Sep; 39(33):7700-5. PubMed ID: 20652177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ABC synthesis and antitumor activity of a series of Annonaceous acetogenin analogs with a threo, trans, threo, trans, threo-bis-tetrahydrofuran core unit.
    Marshall JA; Sabatini JJ; Valeriote F
    Bioorg Med Chem Lett; 2007 May; 17(9):2434-7. PubMed ID: 17329102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and in vitro cytotoxicity evaluation of novel naphthindolizinedione derivatives.
    Defant A; Guella G; Mancini I
    Arch Pharm (Weinheim); 2007 Mar; 340(3):147-53. PubMed ID: 17315260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereoselective total synthesis of (-)-borrelidin.
    Vong BG; Kim SH; Abraham S; Theodorakis EA
    Angew Chem Int Ed Engl; 2004 Jul; 43(30):3947-51. PubMed ID: 15274222
    [No Abstract]   [Full Text] [Related]  

  • 12. Guanaconetins, new antitumoral acetogenins, mitochondrial complex I and tumor cell growth inhibitors.
    Chahboune N; Barrachina I; Royo I; Romero V; Sáez J; Tormo JR; De Pedro N; Estornell E; Zafra-Polo MC; Peláez F; Cortes D
    Bioorg Med Chem; 2006 Feb; 14(4):1089-94. PubMed ID: 16242335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of cryptolepine analogues as potential bioreducible anticancer agents.
    Seville S; Phillips RM; Shnyder SD; Wright CW
    Bioorg Med Chem; 2007 Oct; 15(19):6353-60. PubMed ID: 17643990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potent anticancer activities of novel aminophenol analogues against various cancer cell lines.
    Ohba T; Yamauch T; Higashiyama K; Takahashi N
    Bioorg Med Chem; 2007 Jan; 15(2):847-53. PubMed ID: 17092729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enantioselective total synthesis of borrelidin.
    Duffey MO; LeTiran A; Morken JP
    J Am Chem Soc; 2003 Feb; 125(6):1458-9. PubMed ID: 12568588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, structure and hypoxic cytotoxicity of 3-amino-1,2,4-benzotriazine-1,4-dioxide derivatives.
    Jiang F; Weng Q; Sheng R; Xia Q; He Q; Yang B; Hu Y
    Arch Pharm (Weinheim); 2007 May; 340(5):258-63. PubMed ID: 17464965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxic and Antihaptotactic beauvericin analogues from precursor-directed biosynthesis with the insect pathogen Beauveria bassiana ATCC 7159.
    Xu Y; Zhan J; Wijeratne EM; Burns AM; Gunatilaka AA; Molnár I
    J Nat Prod; 2007 Sep; 70(9):1467-71. PubMed ID: 17803266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenazine-1-carboxamides: structure-cytotoxicity relationships for 9-substituents and changes in the H-bonding pattern of the cationic side chain.
    Gamage SA; Rewcastle GW; Baguley BC; Charlton PA; Denny WA
    Bioorg Med Chem; 2006 Feb; 14(4):1160-8. PubMed ID: 16216514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel angular furoquinolinones bearing flexible chain as antitumor agent: design, synthesis, cytotoxic evaluation, and DNA-binding studies.
    Xie L; Qian X; Cui J; Xiao Y; Wang K; Wu P; Cong L
    Bioorg Med Chem; 2008 Sep; 16(18):8713-8. PubMed ID: 18722129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and cytotoxic activity of a new series of topoisomerase I inhibitors.
    Dallavalle S; Gattinoni S; Mazzini S; Scaglioni L; Merlini L; Tinelli S; Beretta GL; Zunino F
    Bioorg Med Chem Lett; 2008 Feb; 18(4):1484-9. PubMed ID: 18248813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.